Immunocore: Developer of the world’s first approved TCR-therapeutic KIMMTRAK and pioneering a new class of therapeutics to deliver transformative medicines to patients in cancer, infection, and autoimmune. KIMMTRAK generated net revenues of $34M in 2Q22 for patients with metastatic uveal melanoma. Durable clinical activity was presented (ESMO 2022) for PRAME in multiple solid tumors and have initiated four expansion arms.
Based in...
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Anti-infectives, Antivirals, Immuno-Oncology, Immunotherapy, Infectious Disease, Oncology, Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Antibodies, Cell Therapy, Platform Technology
Abingdon, Oxfordshire
United Kingdom

Company Participants at Solebury 1x1 Management Access Event 2023

  • Bahija Jallal, CEO
  • Brian Di Donato, Chief Financial Officer and Head of Strategy
  • Clayton Robertson, Head of Investor Relations
  • David Berman, Head of R&D

Lead Programs


Indication Phase
metastatic uveal Melanoma Marketed
Advanced Melanoma 2/3

Top 10 Holders of Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RTW Investments LP 12.54 6,029,633 312.94 13F 6/30/23
Wellington Management Co. LLP 7.68 3,695,490 191.80 13F 6/30/23
Rock Springs Capital Management LP 6.30 3,028,410 157.17 13F 6/30/23
Baker Bros. Advisors LP 5.24 2,520,731 130.83 13F 6/30/23
T Rowe Price Associates, Inc. (13F Subfiler) 5.04 2,423,420 125.78 13F 6/30/23
T. Rowe Price Associates, Inc. (Investment Management) 4.62 2,221,664 115.30 Funds 6/30/23
Fidelity Management & Research Co. LLC 3.76 1,810,019 93.94 13F 6/30/23
Paradigm BioCapital Advisors LP 2.64 1,270,124 65.92 13F 6/30/23
General Atlantic LLC 1.98 950,000 49.31 13F 6/30/23
Pictet Asset Management SA 1.96 941,773 48.88 13F 6/30/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.